ESCAPE TRIAL
“These results will impact stroke care around the world.”
Standard clot-busting treatment for acute strokes doesn’t work for patients with large clots in major vessels. Through endovascular therapy, however, doctors can make a small incision, insert a catheter, and manually remove the clot.
Dr. Andrew Demchuk, Dr. Mayank Goyal, and Dr. Michael Hill tested the effectiveness of endovascular therapy through the Alberta-based ESCAPE Trial. The study showed that endovascular therapy patients had a 23.7% reduced chance for stroke-related disability and were 50% less likely to die within three months of their stroke.
According to Dr. Hill, “This is the most significant and fundamental change in acute ischemic stroke treatment in the last 20 years… [and] will impact stroke care around the world.”